Trulia Shines on Revenue Beat and Q2 Outlook

Michael Teague |

Trulia Shines on Revenue Beat and Q2 Outlook The online real-estate resource Trulia, Inc. (TRLA) reported better than expected earnings after Tuesday’s close, sending shares soaring in late trading.

With a subscriber base that is growing along with mobile use, the company reported an adjusted net loss of $0.6 million, or $0.02 per share on revenue of $24 million, versus the prior year period’s figures of $3.7 million, or $0.54 cents per share.

The company missed estimates on earnings that had it losing $0.01 per share, but far outpaced revenue expectations of $21.1 million with a 97 percent increase on Q1 of 2012. Furthermore, Trulia increased its revenue guidance for the second quarter to a range of $27.3 million to $27.7 million, versus estimates of $24.5 million.

Trulia reported 31.4 million unique monthly visits during the quarter, up from 20.6 million in the prior year period. Unique visits from mobile more than doubled from 5.1 million in Q1 of 2012 to 11.4 million in Q1 of 2013.

Additionally, the company recorded huge increases in media revenue, total subscribers, average monthly revenue per subscriber, and contributions to user-generated content.

Shares jumped more than 9.3 percent in late trading to $31.77, after closing the regular day at a loss of 1.3 percent, to $29.06.

Trulia’s earnings and especially the increased user activity outlined in the report, come on the same day that February data from the S&P/Case-Schiller composite index that tracks home prices for 20 cities across the United States indicated an increase of 9.3 percent on the prior year. It was the largest annual growth since May of 2006, well before the collapse of the housing bubble.

While home prices are well below their 2006 watermark, all of the index’s 20 cities saw gains on the prior year.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
XKKCL Lehman ABS Corp. 8.00% CorTS Goodyear Tire & Rubbe n/a n/a n/a 0 Trade


Emerging Growth

Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and…

Private Markets

California Green Tree Development

California Green Tree Development LLC (CGTD) is a for-profit LLC that plans on using California’s booming market of legal cannabis products for medical purposes. As an unprecedented resource, Cannabis has…

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…